Legislation - HB1109

Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product unless the purchaser provides to the retailer certain proof; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or a xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine product or a xylazine product to maintain certain records; etc.

Committees

Original:: Health and Government Operations Click to view Recorded Media

Committee Testimony

Witness List

Details

Cross-filed with: SB0875

Bill File Type: Regular

Effective Date(s): October 1, 2025

History

Legislation History
Chamber House Calendar Date 2/05/2025 Legislative Date 2/05/2025 Action First Reading Health and Government Operations Proceedings
Chamber Calendar Date Legislative Date Action Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act Proceedings
Chamber House Calendar Date 2/10/2025 Legislative Date 2/10/2025 Action Hearing 3/05 at 1:00 p.m. Proceedings
Chamber House Calendar Date 3/03/2025 Legislative Date 3/03/2025 Action Hearing canceled Proceedings
Chamber House Calendar Date 3/03/2025 Legislative Date 3/03/2025 Action Hearing 3/05 at 2:00 p.m. Proceedings
Chamber House Calendar Date 3/05/2025 Legislative Date 3/05/2025 Action Hearing canceled Proceedings
Chamber House Calendar Date 3/05/2025 Legislative Date 3/05/2025 Action Hearing 3/05 at 2:40 p.m. Proceedings

Chamber	Calendar Date	Legislative Date	Action
House	2/05/2025	2/05/2025	First Reading Health and Government Operations
			Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act
House	2/10/2025	2/10/2025	Hearing 3/05 at 1:00 p.m.
House	3/03/2025	3/03/2025	Hearing canceled
House	3/03/2025	3/03/2025	Hearing 3/05 at 2:00 p.m.
House	3/05/2025	3/05/2025	Hearing canceled
House	3/05/2025	3/05/2025	Hearing 3/05 at 2:40 p.m.

File Code

Subjects

Statutes